These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 36603672)
1. Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations. Scialla S; Hanafy MS; Wang JL; Genicio N; Costa Da Silva M; Costa M; Oliveira-Pinto S; Baltazar F; Gallo J; Cui Z; Bañobre-López M Int J Pharm; 2023 Feb; 632():122575. PubMed ID: 36603672 [TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Niu M; Valdes S; Naguib YW; Hursting SD; Cui Z Mol Pharm; 2016 Jun; 13(6):1833-42. PubMed ID: 27074028 [TBL] [Abstract][Full Text] [Related]
3. Magnetic Hybrid Wax Nanocomposites as Externally Controlled Theranostic Vehicles: High MRI Enhancement and Synergistic Magnetically Assisted Thermo/Chemo Therapy. de Moura CL; Gallo J; García-Hevia L; Pessoa ODL; Ricardo NMPS; Bañobre-López M Chemistry; 2020 Apr; 26(20):4531-4538. PubMed ID: 31867807 [TBL] [Abstract][Full Text] [Related]
4. Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616 [No Abstract] [Full Text] [Related]
5. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment. Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell. Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098 [TBL] [Abstract][Full Text] [Related]
7. Using anti-PD-L1 antibody conjugated gold nanoshelled poly (Lactic-co-glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer. Jiang H; Zhou Y; Zheng D; Cheng Y; Xiang D; Jiang L; Du J J Biomed Mater Res A; 2024 Mar; 112(3):402-420. PubMed ID: 37941485 [TBL] [Abstract][Full Text] [Related]
8. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics. Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092 [TBL] [Abstract][Full Text] [Related]
9. Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells. Mansur AAP; Mansur HS; Leonel AG; Carvalho IC; Lage MCG; Carvalho SM; Krambrock K; Lobato ZIP J Mater Chem B; 2020 Aug; 8(32):7166-7188. PubMed ID: 32614035 [TBL] [Abstract][Full Text] [Related]
10. ICAM1-Targeting Theranostic Nanoparticles for Magnetic Resonance Imaging and Therapy of Triple-Negative Breast Cancer. Chen J; Lv M; Su X; Wang S; Wang Y; Fan Z; Zhang L; Tang G Int J Nanomedicine; 2022; 17():5605-5619. PubMed ID: 36444196 [TBL] [Abstract][Full Text] [Related]
11. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages. Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614 [TBL] [Abstract][Full Text] [Related]
12. A Multifunctional, Highly Biocompatible, and Double-Triggering Caramelized Nanotheranostic System Loaded with Fe Wang F; Li N; Wang W; Ma L; Sun Y; Wang H; Zhan J; Yu D Int J Nanomedicine; 2023; 18():881-897. PubMed ID: 36844435 [TBL] [Abstract][Full Text] [Related]
13. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
14. Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin. Niu M; Naguib YW; Aldayel AM; Shi YC; Hursting SD; Hersh MA; Cui Z Mol Pharm; 2014 Dec; 11(12):4425-36. PubMed ID: 25314115 [TBL] [Abstract][Full Text] [Related]
15. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094 [TBL] [Abstract][Full Text] [Related]
16. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment. Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321 [TBL] [Abstract][Full Text] [Related]
17. Gold Nanoparticle-Incorporated Chitosan Nanogels as a Theranostic Nanoplatform for CT Imaging and Tumour Chemotherapy. Liu Z; Zhou D; Yan X; Xiao L; Wang P; Wei J; Liao L Int J Nanomedicine; 2022; 17():4757-4772. PubMed ID: 36238536 [TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Huang Y; Mao K; Zhang B; Zhao Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953 [TBL] [Abstract][Full Text] [Related]
19. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice. Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer Falsafi M; Hassanzadeh Goji N; Sh Saljooghi A; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M Expert Opin Drug Deliv; 2022 Jun; 19(6):743-754. PubMed ID: 35616345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]